Skip to main content
Premium Trial:

Request an Annual Quote

Cambridge Antibody Technology Buys TAP Automated Cell Culture System

NEW YORK, April 21 (GenomeWeb News) - The Automation Partnership said yesterday that Cambridge Antibody Technology has purchased a TAP SelecT automated cell culture system.

 

CAT will use the SelecT to automate cell culture of multiple cell lines in parallel, which will then be used in CAT's daily antibody-based drug screening.

 

Financial details were not disclosed.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.